stockrowADC Therapeutics SA (ADCT) vs Organigram Global Inc. (OGI)
- ADC Therapeutics SA ADCT 1.57 −4.27%
- Organigram Global Inc. OGI 0.88 −5.38%
ADC Therapeutics SA and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. ADC Therapeutics SA is the larger, with a market value of $209.4M against $131.1M — 1.6× the size. ADC Therapeutics SA has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.0×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against 3.03%. Organigram Global Inc. has the higher net margin (28.4% vs −121.8%) and the lower return on invested capital (−1.53% vs 0.00%). Across the 17 metrics below, Organigram Global Inc. leads on 11 and ADC Therapeutics SA on 6.
Valuation
Profitability
| Metric | ADCT | OGI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 88.86% | 36.47% | 53.51% |
| Operating margin | (125.08%) | (3.91%) | 0.00% |
| Net margin | (121.77%) | 28.44% | (2.45%) |
| Free cash flow margin | (127.72%) | (9.46%) | 0.00% |
| Return on equity | 45.35% | 20.20% | (0.80%) |
| Return on assets | (32.25%) | 12.70% | (1.67%) |
| Return on invested capital | 0.00% | (1.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack